Home
CAMIPM Seminar Series
"Towards wearable metabolic near-infrared brain imaging for dementia"
Gemma Bale BSc MRes PhD
Gianna Angelopoulos Lecturer in Medical Therapeutics
University of Cambridge
https://www.neuro-optics.group.cam.ac.uk/
Abstract and teaching points:
Broadband near-infrared spectroscopy (bNIRS) is a promising tool for at-home estimation of dementia progression as it can capture vascular and metabolic responses to cognitive tasks. I will present developments towards wearable bNIRS devices and results from a clinical study of dementia (Alzheimer's/Lewy body dementia) with bNIRS.
Date: Thursday, June 20th, 2024
Location: Room 1412 BRB2
Time: 3:00 PM
Zoom link:
https://pennmedicine.zoom.us/j/93435730386?pwd=YmxHa2I5Ny9wWWlZNzBPU3ZJR05sQT09
Meeting ID: 934 3573 0386
Passcode: 897997
Welcome to the Center For Advanced Metabolic Imaging in Precision Medicine (CAMIPM), a National Center for Biomedical Imaging and Bioengineering (NCBIB) in the Perelman School of Medicine at the University of Pennsylvania.
Principal Investigator: Ravinder Reddy, Ph.D., Director and Professor of Radiology
The CAMIPM develops and translates cutting edge noninvasive metabolic imaging biomarkers for use in biomedical research. Technology development is focused in four major application areas: Oncology, Cardiovascular disease, Neuropsychiatry, and Musculoskeletal disorders. These technologies will have substantial impact on the fundamental understanding of disease mechanisms, early diagnosis, and development of novel therapies for several diseases such as Alzheimer’s disease, Epilepsy, Arthritis, Cancer, Stroke, and heart disease, and thus contribute to precision medicine and enhanced patient care. The facility’s core sections provide research and computing resources for numerous user, collaborative, and training projects.
The focus of this center is on developing instrumentation, methodologies, and data analysis techniques for the quantitative assessment of functional, structural, and metabolic parameters in humans with the use of chemical exchange weighted molecular magnetic resonance imaging (MRI), MRI of oxygen consumption, down field spectroscopy, and diffuse optical imaging techniques.
We are supported by the NIBIB under Grant No. P41 EB029460.